Here, we found that human RCC tumors showed reduced HSPA12A accompanied by increased CD147 protein expression, suggesting that downregulation of HSPA12A might increase RCC cell migration by upregulating CD147. This evidence concerns the gene HSPA12A and renal cell adenocarcinoma.